Trade AbbVie ^ABBV

Final Trades: AbbVie, Morgan Stanley, Shake Shack and the CBOE

Best Pharmaceutical Stocks To Consider - June 9th - Stock Observer

Cerity Partners LLC Acquires 62,426 Shares of AbbVie Inc. $ABBV - Markets Daily

Focus Partners Advisor Solutions LLC Buys 13,993 Shares of AbbVie Inc. $ABBV - Markets Daily

Focus Partners Advisor Solutions LLC Has $11.48 Million Stock Position in AbbVie Inc. $ABBV

AbbVie (NYSE:ABBV) Shares Down 1.9% - What's Next? - Markets Daily

Promising Medical Stocks To Research - June 8th - Stock Observer

Dividend Stocks To Research - June 8th - Daily Political

LPL Financial LLC Buys 119,704 Shares of AbbVie Inc. $ABBV

O Shaughnessy Asset Management LLC Boosts Holdings in AbbVie Inc. $ABBV - Stock Observer

AbbVie Inc. $ABBV Shares Sold by Erste Asset Management GmbH

AbbVie Inc. $ABBV Shares Acquired by Fiera Capital Corp

AbbVie (NYSE:ABBV) - Stock Analysis - Simply Wall St

Top Pharmaceutical Stocks To Watch Today - June 7th - Zolmax

Forget Wall Street's Ultimate Pharma Value Trap: Here Is a Far Better Stock to Buy Right Now

Dividend Stocks To Research - June 7th - Daily Political

Capital Research Global Investors Has $5.81 Billion Stake in AbbVie Inc. $ABBV - Zolmax

Capital International Inc. CA Has $69.41 Million Holdings in AbbVie Inc. $ABBV - Zolmax

ING Groep NV Trims Stock Position in AbbVie Inc. $ABBV

AbbVie Inc. $ABBV Shares Sold by Dearborn Partners LLC

Wall Street Zen Downgrades AbbVie (NYSE:ABBV) to Buy

Dearborn Partners LLC Reduces Position in AbbVie Inc. $ABBV - Daily Political

AbbVie Inc. $ABBV Shares Acquired by Capital World Investors - Daily Political

Dividend Stocks To Follow Today - June 6th - Markets Daily

AbbVie (ABBV) Valuation Check After New Cancer And Migraine Drug Approvals

Dividend Stocks To Follow Today - June 6th - Stock Observer

Best Medical Stocks To Follow Now - June 5th - Markets Daily

Assessing AbbVie (ABBV) Valuation After Fresh Regulatory Wins In Migraine And Blood Cancer

AbbVie (ABBV) Announces European Commission's Approval of AQUIPTA®

AbbVie (NYSE:ABBV) Trading 1.2% Higher - What's Next? - Daily Political

Pharmaceutical Stocks To Consider - June 5th - Stock Observer

AbbVie Inc. $ABBV Shares Purchased by Westfield Capital Management Co. LP

Vise Technologies Inc. Acquires 25,198 Shares of AbbVie Inc. $ABBV

WCG Wealth Advisors LLC Buys Shares of 17,087 AbbVie Inc. $ABBV

12,757 Shares in AbbVie Inc. $ABBV Bought by Total Wealth Planning & Management Inc.

J.W. Cole Advisors Inc. Cuts Stake in AbbVie Inc. $ABBV

AbbVie Inc. $ABBV Shares Bought by Prestige Wealth Management Group LLC - Stock Observer

AbbVie (NYSE:ABBV) Shares Unloaded Rep. Josh Gottheimer

Clifford Swan Investment Counsel LLC Sells 3,532 Shares of AbbVie Inc. $ABBV - Stock Observer

AbbVie (NYSE:ABBV) Stock Unloaded Rep. Josh Gottheimer - Stock Observer

NICE Endorses AbbVie's Elahere for Treating Ovarian Cancer, ETPharma

Elahere's NHS Approval Tests AbbVie's Oncology Expansion And Investor Thesis

AbbVie (NYSE:ABBV) Shares Up 3.5% - Here's What Happened

Aldeyra Therapeutics Eyes FDA Feedback as Dry Eye Drug Faces Make-or-Break Moment - Stock Observer

5 Best Cheap Stocks to Buy for Beginners

Greenspring Advisors LLC Grows Stake in AbbVie Inc. $ABBV

AbbVie Inc. $ABBV Shares Sold by TD Asset Management Inc

Top Medical Stocks To Research - June 4th - Daily Political

AbbVie Inc. $ABBV Shares Bought by Cibc World Market Inc.

Promising Medical Stocks To Research - June 3rd - Zolmax

Bank of New York Mellon Corp Raises Stock Holdings in AbbVie Inc. $ABBV - Zolmax

AbbVie Delivers 400% Returns Beating The S&P 500 by 139% - AOL

Top 5 High-Yield Dividend Stocks for Income Investors in 2026

This Is What a $1 Million Dividend Portfolio Pays After Taxes

The Bull Case For AbbVie (ABBV) Could Change Following EU Approval Of AQUIPTA For Acute Migraine

AbbVie Inc. $ABBV Stock Holdings Increased by BNP Paribas - Stock Observer

Revenue Rises 27.5%; AbbVie Pact Marks Key FY26 Milestone

COFG Advisors LLC Invests $4.09 Million in AbbVie Inc. $ABBV - Stock Observer

AbbVie (NYSE:ABBV) Shares Up 1.4% - Here's What Happened - Daily Political

Consensus meta-analysis of genome-wide association studies for Alzheimer's disease and related dementias

Clonal Hematopoiesis does not influence manufacturing of Chimeric Antigen Receptor (CAR) T-Cells

AbbVie (ABBV) to Attend Goldman Sachs Global Healthcare Conference

Johnson & Johnson Hopes to Dethrone AbbVie's Biggest Growth Driver. Here's Why Investors Shouldn't Panic - AOL

AbbVie Inc. (ABBV) Announces EC Authorization of Expanded Label for VENCLYXTO®

Is AbbVie Inc. (ABBV) Expanding Its Oncology Pipeline With New BPDCN Treatment Approval?

17,902 Shares in AbbVie Inc. $ABBV Purchased by COFG Advisors LLC

Glenmark Pharmaceuticals Ltd (BOM:532296) Q4 2026 Earnings Call Highlights: Strong Revenue ...

Access to CAR-T cell therapy in Central and Eastern Europe: persistent barriers and inequalities as of October/November 2025

Promising Pharmaceutical Stocks To Follow Now - June 1st - Zolmax

Natera And 2 Other Companies That May Be Trading Below Their Estimated Value

AbbVie Inc. $ABBV Shares Bought by Hillsdale Investment Management Inc.

AbbVie Inc. (NYSE:ABBV) Given Consensus Recommendation of "Moderate Buy" by Brokerages - Daily Political

Analysts Have Conflicting Sentiments on These Healthcare Companies: Krystal Biotech (KRYS), AbbVie (ABBV) and Tempus AI, Inc. Class A (TEM)

SEZ6-targeting antibody−drug conjugate ABBV-706 in advanced small cell lung cancer and solid tumors: a phase 1 trial

Privacy preserving digital platform for patient reported outcomes in inflammatory bowel disease

Botulinum Toxin Drugs Market Demand and Future Opportunities - Express Press Release Distribution

AbbVie Inc. $ABBV Shares Bought by MUFG Securities EMEA plc

Railway Pension Investments Ltd Has $196.44 Million Stock Holdings in AbbVie Inc. $ABBV - Stock Observer

AbbVie Inc. $ABBV Shares Sold by Welch & Forbes LLC - Stock Observer

AbbVie Inc. $ABBV Position Increased by MUFG Securities EMEA plc - Daily Political

Investment Analysts' Upgrades for May 30th (A, ABBV, ACA, AFCG, AKAN, ALLR, ALRS, ASUR, AXIA, BILL) - Stock Observer

SBI Okasan Asset Management Co.Ltd. Acquires New Shares in AbbVie Inc. $ABBV - Zolmax

Intech Investment Management LLC Sells 2,467 Shares of AbbVie Inc. $ABBV - Stock Observer

SBI Okasan Asset Management Co.Ltd. Buys New Holdings in AbbVie Inc. $ABBV - Daily Political

AbbVie (NYSE:ABBV) Raised to Strong-Buy at Wall Street Zen

Norges Bank Takes $5.87 Billion Position in AbbVie Inc. $ABBV - Daily Political

Eurizon Capital SGR S.p.A. Acquires Shares of 1,554,089 AbbVie Inc. $ABBV - Daily Political

AbbVie (ABBV) Expands Venclyxto Label for Chronic Lymphocytic Leukemia Treatment

VYM Climbs 26% In a Year While Its Core Dividend Payers Extend Their Streaks

AbbVie Stock: Is ABBV Outperforming the Healthcare Sector?

Rothschild Investment LLC Reduces Position in AbbVie Inc. $ABBV - Zolmax

AbbVie's VENCLYXTO Label Gets EU Approval For Chronic Lymphocytic Leukemia Treatment

US Economy on Stagflation Watch: Apollo Global Management's Outlook

AI Podcast: Fresh Insights on Fed Rate Cut Timing - News in a New Way

Week Ahead: Growth, Inflation, and Consumer Trends in Focus

Week Ahead: China Is On Holiday, But The BoC, The Fed, And The ECB Will Be Busy With The First 2025 Rate Announcements 

Week ahead: Magnificent 7 earnings, 2 key inflation reports

Week ahead: Earnings bonanza, ECB decision & US inflation

Week ahead: Fed, ECB & BoJ in action

Trump's Sudden Russia Policy Shift: Rubio's Influence and Implications

Global Market Review: Gold Volatility and Tech Stock Surge Amidst Economic Uncertainty

September CPI Data: Inflation Hurdles, Tariff Impacts, and Fed Rate Cut Expectations

Navigating the AI Boom: Strategies for Investors Amid Nvidia's Valuation Surge

Fund Managers Cautious in Q4: AI, Inflation, and Monetary Policy in Focus

US Government Shutdown Threatens October Inflation Data Release

US-EU Relations: Russia Sanctions Unite Despite Trade Tensions

BOJ Warns of Japan Stock Market Overheating, U.S. Trade Policy Risk